Item 2.02. Results of Operations and Financial Condition.

On January 11, 2023, Ginkgo Bioworks Holdings, Inc. issued a press release announcing certain preliminary unaudited revenue highlights and performance updates for the year ended December 31, 2022. A copy of the press release is furnished with this Current Report on Form 8-K as Exhibit 99.1.

The information contained in Item 2.02 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any general incorporation language in such filing.

Item 9.01. Financial Statements and Exhibits.



(d) Exhibits.

Exhibit
Number    Description



99.1      Press Release, issued by Ginkgo Bioworks Holdings, Inc. on January 11,
        2023

104         Cover Page Interactive Data File (formatted as Inline XBRL and contained
            in Exhibit 101)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses